IP Library › Granted Patent US 10,385,214
Granted Patent B2
US 10,385,214 · App. 15/719,216 · Granted Aug 20, 2019

Fluorescent dyes and their uses as biomarkers

Inventor: Nikolai Romanov (Cambridge, GB)
Assignee: Illumina Cambridge Limited
C09B62/365C07D417/04C07D491/04C09K11/06C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,385,214
App. No.
15/719,216
Granted
Aug 20, 2019
Kind
B2
Abstract

The present application relates to new fluorescent dyes and their uses as fluorescent labels. The compounds may be used as fluorescent labels for nucleotides in nucleic acid sequencing applications.

Claims (85)

1. A compound of Formula (I) or mesomeric forms thereof:

wherein each R 1 , R 2 , and R 1 ′ is independently selected from the group consisting of H, alkyl, substituted alkyl, alkoxy, alkenyl, alkynyl, haloalkyl, haloalkoxy, alkoxyalkyl, amino, aminoalkyl, aminosulfonyl, halo, cyano, hydroxy, hydroxyalkyl, heteroalkyl, C-carboxy, O-carboxy, C-amido, N-amido, nitro, sulfonyl, sulfo, sulfino, sulfonate, sulfonyl halide, S-sulfonamido, N-sulfonamido, optionally substituted carbocyclyl, optionally substituted aryl, optionally substituted heteroaryl and optionally substituted heterocyclyl;

alternatively, R 1 and R 1 ′ together and with the atoms to which they are attached form a ring or ring system selected from the group consisting of optionally substituted carbocyclyl, optionally substituted aryl, optionally substituted heteroaryl, and optionally substituted heterocyclyl;

each R 3 and R 4 is independently selected from the group consisting of H, alkyl, substituted alkyl, alkenyl, alkynyl, aminoalkyl, haloalkyl, heteroalkyl, alkoxyalkyl, sulfonyl hydroxide, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted carbocyclyl, and optionally substituted heterocyclyl;

alternatively, R 1 and R 3 together with the atoms to which they are attached form a ring or ring system selected from the group consisting of optionally substituted 5-10 membered heteroaryl and optionally substituted 5-10 membered heterocyclyl;

alternatively, R 2 and R 4 together with the atoms to which they are attached form a ring or ring system selected from the group consisting of optionally substituted 5-10 membered heteroaryl and optionally substituted 5-10 membered heterocyclyl;

R 5 and R 6 is independently selected from the group consisting of alkyl, substituted alkyl, alkoxy, alkenyl, alkynyl, haloalkyl, haloalkoxy, alkoxyalkyl, amino, aminoalkyl, aminosulfonyl, halo, cyano, hydroxy, hydroxyalkyl, heteroalkyl, C-carboxy, O-carboxy, C-amido, N-amido, nitro, sulfonyl, sulfo, sulfino, sulfonate, sulfonyl halide, S-sulfonamido, N-sulfonamido, optionally substituted carbocyclyl, optionally substituted aryl, optionally substituted heteroaryl and optionally substituted heterocyclyl;

R is —OR 7 or —NR 8 R 9 ;

R 7 is selected from the group consisting of H, alkyl, substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted carbocyclyl, and optionally substituted heterocyclyl;

each R 8 and R 9 is independently selected from the group consisting of H, alkyl, substituted alkyl, alkenyl, alkynyl, aminoalkyl, carboxyalkyl, sulfonatoalkyl, haloalkyl, heteroalkyl, alkoxyalkyl, sulfo, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted carbocyclyl, and optionally substituted heterocyclyl;

X is selected from the group consisting of O, S, NR 10 , and Se;

R 10 is selected from the group consisting of H, alkyl, substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted carbocyclyl, and optionally substituted heterocyclyl;

m is an integer selected from 0 to 4; and

n is an integer selected from 0 to 4; provided that

when each R 1 , R 1 ′ and R 2 is H; each R 3 and R 4 is ethyl; each m and n is 0; R is —NHCH(CH 3 )CH 2 OH; then X is O, S or Se;

when each R 1 , R 1 ′ and R 2 is H; each R 3 and R 4 is ethyl; each m and n is 0; R is—OH; then X is S or Se;

when each R 1 , R 1 ′ and R 2 is H; each R 3 and R 4 is ethyl; m is 1 and R 5 is methyl; n is 0; R is —OH or —OEt; then X is S, NR 10 or Se; and

when each R 1 , R 1 ′ and R 2 is H; each R 3 and R 4 is ethyl; m is 1 and R 5 is —S(O 2 )Et; n is 0; R is —OH or —OEt; then X is S, NR 10 or Se.

2. The compound of claim 1 , wherein X is S or O.

3. The compound of claim 1 , wherein R is —OR 7 .

4. The compound of claim 1 , wherein R 7 is H or alkyl.

5. The compound of claim 1 , wherein R is —NR 8 R 9 .

6. The compound of claim 5 , wherein each R 8 and R 9 is H.

7. The compound of claim 5 , wherein R 8 is H and R 9 is alkyl or substituted alkyl.

8. The compound of claim 5 , wherein both R 8 and R 9 are alkyl or substituted alkyl.

9. The compound of claim 7 , wherein substituted alkyl is selected from alkyl substituted with carboxyl or sulfonyl hydroxide.

10. The compound of claim 1 , wherein each R 1 , R 1 ′ and R 2 is H.

11. The compound of claim 1 , wherein at least one of R 1 , R 1 ′ and R 2 is an alkyl.

12. The compound of claim 1 , wherein each R 3 and R 4 is an alkyl.

13. The compound of claim 12 , wherein each R 3 and R 4 is selected from methyl or ethyl.

14. The compound of claim 1 , wherein R 3 is H and R 4 is an alkyl.

15. The compound of claim 1 , wherein R 1 and R 3 together with the atoms to which they are attached form an optionally substituted 3 to 7 membered heterocyclyl.

16. The compound of claim 15 , wherein R 1 and R 3 together with the atoms to which they are attached form an optionally substituted 6 membered heterocyclyl.

17. The compound of claim 15 , wherein R 4 is selected from H or alkyl.

18. The compound of claim 15 , wherein at least one of R 1 ′ and R 2 is H.

19. The compound of claim 1 , wherein R 2 and R 4 together with the atoms to which they are attached form an optionally substituted 3 to 7 membered heterocyclyl.

20. The compound of claim 19 , wherein R 2 and R 4 together with the atoms to which they are attached form an optionally substituted 6 membered heterocyclyl.

21. The compound of claim 19 , wherein R 3 is selected from H or alkyl.

22. The compound of claim 19 , wherein at least one of R 1 ′ and R 1 is H.

23. The compound of claim 1 , wherein R 1 and R 3 together with the atoms to which they are attached form an optionally substituted 3 to 7 membered heterocyclyl, and wherein R 2 and R 4 together with the atoms to which they are attached form an optionally substituted 3 to 7 membered heterocyclyl.

24. The compound of claim 23 , wherein R 1 and R 3 together with the atoms to which they are attached form an optionally substituted 3 to 7 membered heterocyclyl, and wherein R 2 and R 4 together with the atoms to which they are attached form an optionally substituted 6 membered heterocyclyl.

25. The compound of claim 15 , wherein the heterocyclyl contains one heteroatom.

26. The compound of claim 24 , wherein the heterocyclyl is substituted with one or more alkyl.

27. The compound of claim 1 , wherein m is 0.

28. The compound of claim 1 , wherein m is 1 and R 5 is selected from halo, sulfo, aminosulfonyl, or sulfonyl halide.

29. The compound of claim 1 , wherein n is 0.

30. The compound of claim 1 , selected from the group consisting of:

and mesomeric isomers thereof.

31. The compound of claim 1 , wherein the compound is covalently attached to a nucleotide or oligonucleotide via C(═O)R, wherein R is —OR 7 , and wherein R 7 is H or a substituted alkyl.

32. The compound of claim 1 , wherein the compound is covalently attached to a nucleotide or oligonucleotide via C(═O)R, wherein R is —NR 8 R 9 , and wherein at least one of R 8 or R 9 is a substituted alkyl.

33. A nucleotide or oligonucleotide labeled with a compound according to claim 1 .

34. The labeled nucleotide or oligonucleotide of claim 33 , wherein the compound is covalently attached to the nucleotide or oligonucleotide via —C(═O)R, wherein R is —OR 7 , and R 7 is H or a substituted alkyl.

35. The labeled nucleotide or oligonucleotide of claim 33 , wherein the compound is covalently attached to the nucleotide or oligonucleotide via —C(═O)R, wherein R is —NR 8 R 9 , and wherein at least one of R 8 or R 9 is a substituted alkyl.

36. The labeled nucleotide or oligonucleotide of claim 33 , wherein the compound is attached to the C5 position of a pyrimidine base or the C7 position of a 7-deaza purine base of the nucleotide or oligonucleotide through a cleavable linker.

37. The labeled nucleotide or oligonucleotide of claim 33 , further comprising a 3′—OH blocking group covalently attached to the ribose or deoxyribose sugar of the nucleotide or oligonucleotide.

38. A kit comprising one or more nucleotides wherein at least one nucleotide is a labeled nucleotide according to claim 33 .

39. The kit of claim 38 , comprising two or more labeled nucleotides.

40. The kit of claim 39 , wherein the two labeled nucleotides are excited using a single laser.

41. The kit of claim 38 , further comprising a third and a fourth nucleotide, wherein each of the second, third and fourth nucleotide is labeled with a different compound, wherein each compound has a distinct absorbance maximum and each of the compound is distinguishable from the other compounds.

42. A method of sequencing comprising incorporating a labeled nucleotide according to claim 33 in a sequencing assay.

43. The method of claim 42 , further comprising detecting the nucleotide.

44. The method of claim 42 , wherein the sequencing assay is performed on an automated sequencing instrument, and wherein the automated sequencing instrument comprises two light sources operating at different wavelengths.

45. A method of preparing a compound of Formula (Ia), comprising:

reacting a compound of Formula (IIa)

 or (IIb)

 with a compound of Formula (III)

 to form

wherein each R 1 , R 2 , and R 1 ′ is independently selected from the group consisting of H, alkyl, substituted alkyl, alkoxy, alkenyl, alkynyl, haloalkyl, haloalkoxy, alkoxyalkyl, amino, aminoalkyl, aminosulfonyl, halo, cyano, hydroxy, hydroxyalkyl, heteroalkyl, C-carboxy, O-carboxy, C-amido, N-amido, nitro, sulfonyl, sulfo, sulfino, sulfonate, sulfonyl halide, S-sulfonamido, N-sulfonamido, optionally substituted carbocyclyl, optionally substituted aryl, optionally substituted heteroaryl and optionally substituted heterocyclyl;

alternatively, R 1 and R 1 ′ together and with the atoms to which they are attached form a ring or ring system selected from the group consisting of optionally substituted carbocyclyl, optionally substituted aryl, optionally substituted heteroaryl, and optionally substituted heterocyclyl;

each R 3 and R 4 is independently selected from the group consisting of H, alkyl, substituted alkyl, alkenyl, alkynyl, aminoalkyl, haloalkyl, heteroalkyl, alkoxyalkyl, sulfonyl hydroxide, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted carbocyclyl, and optionally substituted heterocyclyl;

alternatively, R 1 and R 3 together with the atoms to which they are attached form a ring or ring system selected from the group consisting of optionally substituted 5-10 membered heteroaryl and optionally substituted 5-10 membered heterocyclyl;

alternatively, R 2 and R 4 together with the atoms to which they are attached form a ring or ring system selected from the group consisting of optionally substituted 5-10 membered heteroaryl and optionally substituted 5-10 membered heterocyclyl;

R 5 and R 6 is independently selected from the group consisting of alkyl, substituted alkyl, alkoxy, alkenyl, alkynyl, haloalkyl, haloalkoxy, alkoxyalkyl, amino, aminoalkyl, aminosulfonyl, halo, cyano, hydroxy, hydroxyalkyl, heteroalkyl, C-carboxy, O-carboxy, C-amido, N-amido, nitro, sulfonyl, sulfo, sulfino, sulfonate, sulfonyl halide, S-sulfonamido, N-sulfonamido, optionally substituted carbocyclyl, optionally substituted aryl, optionally substituted heteroaryl and optionally substituted heterocyclyl;

X is selected from the group consisting of O, S, NR 10 , and Se;

R 10 is selected from the group consisting of H, alkyl, substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted carbocyclyl, and optionally substituted heterocyclyl;

R″ is selected from the group consisting of H, optionally substituted alkyl, alkenyl, alkynyl, aminoalkyl, haloalkyl, heteroalkyl, alkoxyalkyl, sulfo, optionally substituted aryl; optionally substituted heteroaryl, optionally substituted carbocyclyl, and optionally substituted heterocyclyl;

m is an integer selected from 0 to 4; and

n is an integer selected from 0 to 4.

46. A method for preparation a compound of Formula (Ib), comprising:

converting a compound of Formula (Ia) to a compound of Formula (Ia′) through carboxylic acid activation;

and

reacting the compound of Formula (Ia') with a primary or secondary amine of Formula (IV),

wherein the compound of Formula (Ia) is prepared according to claim 45 ;

R 7 is selected from the group consisting of H, alkyl, substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted carbocyclyl, and optionally substituted heterocyclyl; and

each R 8 and R 9 is independently selected from the group consisting of H, alkyl, substituted alkyl, alkenyl, alkynyl, aminoalkyl, carboxyalkyl, sulfonatoalkyl, haloalkyl, heteroalkyl, alkoxyalkyl, sulfo, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted carbocyclyl, and optionally substituted heterocyclyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2017
From: ROMANOV, NIKOLAI NIKOLAEVICH
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 044324/0773 →
Continuity (2)
Provisional Application 62402635 · Sep 30, 2016
Related Publication 20180094140A1 · Apr 5, 2018